Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes

被引:190
作者
Wannamethee, SG
Shaper, AG
Walker, M
机构
[1] Royal Free Hosp, Dept Primary Care & Populat Sci, London NW3 2PF, England
[2] UCL, Sch Med, London W1N 8AA, England
关键词
D O I
10.1136/jech.2003.015651
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Context: The benefit of weight reduction for cardiovascular disease (CVD) outcomes remains uncertain. Objective: To examine the effects of baseline body mass index on major CVD outcomes and diabetes over a 20 year follow up, and of weight change in the first five years over the subsequent 15 years. Design and setting: A prospective study of British men followed up for 20 years. Participants: Men aged 40-59 years with no diagnosis of CVD or diabetes (n=7176) of whom 6798 provided full information on weight change five years later. Outcome measures: Major CVD events (fatal and non-fatal myocardial infarction and stroke, angina, "other'' CVD deaths) and diabetes. Results: During the 20 year follow up there were 1989 major CVD events and 449 incident cases of diabetes in the 7176 men. Risk of major CVD and diabetes increased significantly with increasing overweight and obesity. During the 15 year follow up, weight gain was associated with increased risk of CVD and diabetes. Weight loss was associated with lower risk of diabetes than the stable group irrespective of initial weight. No significant cardiovascular benefit was seen for weight loss in any men, except possibly in considerably overweight (BMI 27.5-29.9 kg/m(2)) younger middle aged men (RR=0.42; 95% CI 0.22 to 0.81). Conclusion: Long term risk of CVD and diabetes increased significantly with increasing overweight and obesity. Weight loss was associated with significant reduction in risk of diabetes but not CVD, except possibly in considerably overweight younger men. Duration and severity of obesity seem to limit the cardiovascular benefits of weight reduction in older men.
引用
收藏
页码:134 / 139
页数:6
相关论文
共 43 条
  • [1] [Anonymous], 1982, MINNESOTA CODE RESTI
  • [2] OBESITY, ATHEROSCLEROSIS, AND CORONARY-ARTERY DISEASE
    BARRETTCONNOR, EL
    [J]. ANNALS OF INTERNAL MEDICINE, 1985, 103 (06) : 1010 - 1019
  • [3] Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898
  • [4] *BRIT NUTR FDN TAS, 1999, OBESITY
  • [5] WEIGHT-GAIN AS A RISK FACTOR FOR CLINICAL DIABETES-MELLITUS IN WOMEN
    COLDITZ, GA
    WILLETT, WC
    ROTNITZKY, A
    MANSON, JE
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 122 (07) : 481 - 486
  • [6] COX DR, 1972, J R STAT SOC B, V34, P187
  • [7] Associations of weight change and weight variability with cardiovascular and all-cause mortality in the Chicago Western Electric Company Study
    Dyer, AR
    Stamler, J
    Greenland, P
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (04) : 324 - 333
  • [8] Galanis DJ, 1998, AM J EPIDEMIOL, V147, P379
  • [9] GOLDSTEIN DJ, 1992, INT J OBESITY, V16, P397
  • [10] Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults
    Heymsfield, SB
    Segal, KR
    Hauptman, J
    Lucas, CP
    Boldrin, MN
    Rissanen, A
    Wilding, JPH
    Sjöström, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (09) : 1321 - 1326